PT85525A - Arzneimittel enthaltend dipyridamol oder mopidamol und o-acetylsalicylsaeure bzw deren physiologish vertragliche salze verfahren zu ihrer herstellung und ihre verwendung bekampfung der thrombusbildung - Google Patents

Arzneimittel enthaltend dipyridamol oder mopidamol und o-acetylsalicylsaeure bzw deren physiologish vertragliche salze verfahren zu ihrer herstellung und ihre verwendung bekampfung der thrombusbildung

Info

Publication number
PT85525A
PT85525A PT85525A PT8552587A PT85525A PT 85525 A PT85525 A PT 85525A PT 85525 A PT85525 A PT 85525A PT 8552587 A PT8552587 A PT 8552587A PT 85525 A PT85525 A PT 85525A
Authority
PT
Portugal
Prior art keywords
mopidamol
dipyridamol
physiological
thrombus formation
production
Prior art date
Application number
PT85525A
Other languages
German (de)
English (en)
Other versions
PT85525B (pt
Inventor
Wolfgang Eisert
Peter Gruber
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6307286&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT85525(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of PT85525A publication Critical patent/PT85525A/pt
Publication of PT85525B publication Critical patent/PT85525B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT85525A 1986-08-13 1987-08-12 Processo para a preparacao de composicoes farmaceuticas contendo uma mistura de 2,6-bis-(dietanolamino)-4,8-dipiperidino-(5,4-d)-pirimidina (dipiridamol) ou de 2,6-bis-(dietanolamino)-8-piperidino-(5,4-d)-pirimidina (mopidamol) ou um dos seus sais fisiologicamente aceitaveis com acido o-acetilsalicilico PT85525B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863627423 DE3627423A1 (de) 1986-08-13 1986-08-13 Arzneimittel enthaltend dipyridamol oder mopidamol und o-acetylsalicylsaeure bzw. deren physiologisch vertraegliche salze, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung der thrombusbildung

Publications (2)

Publication Number Publication Date
PT85525A true PT85525A (de) 1987-09-01
PT85525B PT85525B (pt) 1990-06-29

Family

ID=6307286

Family Applications (1)

Application Number Title Priority Date Filing Date
PT85525A PT85525B (pt) 1986-08-13 1987-08-12 Processo para a preparacao de composicoes farmaceuticas contendo uma mistura de 2,6-bis-(dietanolamino)-4,8-dipiperidino-(5,4-d)-pirimidina (dipiridamol) ou de 2,6-bis-(dietanolamino)-8-piperidino-(5,4-d)-pirimidina (mopidamol) ou um dos seus sais fisiologicamente aceitaveis com acido o-acetilsalicilico

Country Status (26)

Country Link
US (1) US6015577A (pt)
EP (1) EP0257344B1 (pt)
JP (1) JP2593879B2 (pt)
KR (1) KR950009098B1 (pt)
AT (1) ATE59961T1 (pt)
AU (1) AU603146B2 (pt)
BR (1) BR1100593A (pt)
CA (1) CA1302272C (pt)
CL (1) CL2004001252A1 (pt)
DD (1) DD263918A5 (pt)
DE (3) DE3627423A1 (pt)
DK (1) DK172236B1 (pt)
ES (1) ES2020974B3 (pt)
FI (1) FI873492L (pt)
GR (1) GR3001695T3 (pt)
HK (1) HK14494A (pt)
HU (1) HU202404B (pt)
IE (1) IE60862B1 (pt)
IL (1) IL83510A (pt)
NL (1) NL990001I2 (pt)
NO (2) NO175132C (pt)
NZ (1) NZ221424A (pt)
PH (1) PH27176A (pt)
PT (1) PT85525B (pt)
SG (1) SG122593G (pt)
ZA (1) ZA875947B (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19927689A1 (de) * 1999-06-17 2000-12-21 Gruenenthal Gmbh Orale Darreichungsformen zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac
EP1093814A1 (en) * 1999-10-22 2001-04-25 Boehringer Ingelheim Pharma KG Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders
US7064130B2 (en) * 2001-04-20 2006-06-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of radical-scavenging compounds for treatment and prevention of NO-dependent microcirculation disorders
US20040058056A1 (en) * 2001-07-06 2004-03-25 Shigemasa Osaki Drug diffusion coatings, applications and methods
MXPA04003266A (es) * 2001-10-05 2004-07-08 Combinatorx Inc Combinaciones para el tratamiento de desodrdenes inmuno-inflamatorios.
TW200301135A (en) * 2001-12-27 2003-07-01 Otsuka Maryland Res Inst Inc Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor
DE10209982A1 (de) * 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Oral zu applizierende Darreichungsform für schwerlösliche basische Wirkstoffe
US20030181488A1 (en) * 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
US7485322B2 (en) * 2002-12-24 2009-02-03 Lek Pharmaceuticals D.D. Modified release pharmaceutical composition
JP2006516593A (ja) * 2003-02-07 2006-07-06 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｍｍｐ−９依存性疾患の治療及び予防のためのジピリダモール又はモピダモールの使用
DE10306179A1 (de) 2003-02-13 2004-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Dipyridamol in Kombination mit Acetylsalicylsäure und einem Angiotensin II-Antagonisten zur Schlaganfall-Prophylaxe
RU2005136383A (ru) * 2003-04-24 2007-06-10 БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) Применение дипиридамола или мопидамола для лечения и предупреждения тромбоэмболических заболеваний и нарушений, вызываемыхизбыточным образованием и/или повышенным уровнем экспрессии тромбиновых рецепторов
US7041286B2 (en) * 2003-07-23 2006-05-09 Nerenberg Arnold P Composition for mitigating a pernicious thrombotic event
TW200517114A (en) * 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
CN101068570A (zh) * 2004-05-13 2007-11-07 贝林格尔·英格海姆国际有限公司 双嘧达莫治疗血小板抑制剂的抗药性的用途
RU2403033C2 (ru) 2005-03-22 2010-11-10 Лозан Фарма Гмбх Солюбилизированный ибупрофен
CA2619035A1 (en) * 2005-08-22 2007-03-01 Novartis Ag Pharmaceutical compositions
EP2387994A1 (en) * 2006-01-27 2011-11-23 Eurand, Inc. Drug delivery systems comprising weakly basic drugs and organic acids
US20070190145A1 (en) * 2006-01-27 2007-08-16 Eurand, Inc. Drug delivery systems comprising weakly basic selective serotonin 5-ht3 blocking agent and organic acids
CN101365453A (zh) * 2006-02-09 2009-02-11 特瓦制药工业有限公司 双嘧达莫缓释制剂及其制备方法
CA2652773A1 (en) * 2006-05-22 2007-12-06 Combinatorx, Incorporated Methods and compositions for the treatment of diseases or conditions associated with increased c-reactive protein, interleukin-6, or interferon-gamma levels
ITRM20060460A1 (it) * 2006-08-31 2006-11-30 Univ Roma Uso di acido acetil salicilico in combinazione con inibitori dei canali mrp4 per il trattamento di pazienti resistenti a detto acido acetil salicilico
CA2677623C (en) * 2007-02-09 2015-04-07 Alphapharm Pty Ltd A dosage form containing two or more active pharmaceutical ingredients in different physical forms
CA2737131A1 (en) * 2007-09-19 2009-03-26 Zalicus Inc. Therapeutic regimens for the treatment of immunoinflammatory disorders
JP2011506607A (ja) * 2007-12-17 2011-03-03 ザリカス インコーポレイティッド 免疫炎症性障害の処置のための治療法
US20090196935A1 (en) * 2008-02-01 2009-08-06 Ahmed Salah U Pharmaceutical Capsules Comprising Extended Release Dipyridamole Pellets
US8133506B2 (en) * 2008-03-12 2012-03-13 Aptalis Pharmatech, Inc. Drug delivery systems comprising weakly basic drugs and organic acids
CA2716642C (en) 2008-03-28 2017-02-28 Boehringer Ingelheim International Gmbh Method for manufacturing acid pellets
WO2010036975A2 (en) * 2008-09-25 2010-04-01 Teva Pharmaceutical Industries Ltd. Dipyridamole and acetylsalicylic acid formulations and process for preparing same
US20110003005A1 (en) * 2009-07-06 2011-01-06 Gopi Venkatesh Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions
EP2361615A1 (en) 2010-02-19 2011-08-31 Alfred E. Tiefenbacher GmbH & Co. KG Dipyridamole prolonged-release tablet
WO2012162492A1 (en) * 2011-05-24 2012-11-29 Teva Pharmaceutical Industries Ltd. Compressed core comprising organic acids for a pharmaceutical composition
CN103239724A (zh) * 2013-05-27 2013-08-14 成都自豪药业有限公司 抗血栓形成的联合用药物及其药物组合物
WO2018236899A1 (en) * 2017-06-19 2018-12-27 The Cleveland Clinic Foundation Treating disease and promoting weight loss by inhibiting the tma/fmo3/tmao pathway

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2368280A1 (fr) * 1976-10-20 1978-05-19 Theramex Nouvelle composition therapeutique presentant une activite anti-agregante plaquettaire, et son procede de preparation
FR2368272A1 (fr) * 1976-10-20 1978-05-19 Theramex Compositions therapeutiques solides pour combattre l'agregation plaquettaire
LU77353A1 (pt) * 1977-05-16 1979-01-19
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
FR2513118A1 (fr) * 1981-09-18 1983-03-25 Rocador Sa Composition pharmaceutique a base de dipyridamol et de sel d'aluminium de l'acide acetylsalicylique pour combattre l'agregation plaquettaire
ATE50497T1 (de) * 1984-07-21 1990-03-15 Hoechst Ag Kombinationspraeparat aus pyrimido-pyrimidinen und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung.

Also Published As

Publication number Publication date
AU603146B2 (en) 1990-11-08
HK14494A (en) 1994-03-04
JPS6348219A (ja) 1988-02-29
IE872152L (en) 1988-02-13
IE60862B1 (en) 1994-08-24
IL83510A (en) 1992-02-16
NO873370L (no) 1988-02-15
EP0257344A1 (de) 1988-03-02
NO1999014I1 (no) 1999-07-01
DE10299015I2 (de) 2005-06-16
ZA875947B (en) 1989-04-26
ATE59961T1 (de) 1991-02-15
DK172236B1 (da) 1998-02-02
KR950009098B1 (en) 1995-08-14
DE3767408D1 (de) 1991-02-21
NO175132C (no) 1994-09-07
JP2593879B2 (ja) 1997-03-26
ES2020974B3 (es) 1991-10-16
HUT44937A (en) 1988-05-30
DD263918A5 (de) 1989-01-18
BR1100593A (pt) 2002-04-02
NL990001I2 (nl) 2000-04-03
DK421187A (da) 1988-02-14
CL2004001252A1 (es) 2005-03-04
FI873492A7 (fi) 1988-02-14
DK421187D0 (da) 1987-08-12
NO873370D0 (no) 1987-08-12
NO175132B (no) 1994-05-30
SG122593G (en) 1994-06-10
HU202404B (en) 1991-03-28
US6015577A (en) 2000-01-18
DE10299015I1 (de) 2002-10-10
IL83510A0 (en) 1988-01-31
FI873492A0 (fi) 1987-08-12
EP0257344B1 (de) 1991-01-16
AU7679587A (en) 1988-02-18
FI873492L (fi) 1988-02-14
CA1302272C (en) 1992-06-02
NZ221424A (en) 1989-11-28
GR3001695T3 (en) 1992-11-23
NL990001I1 (nl) 1999-03-01
PH27176A (en) 1993-04-02
PT85525B (pt) 1990-06-29
DE3627423A1 (de) 1988-02-18
KR880002529A (ko) 1988-05-09

Similar Documents

Publication Publication Date Title
PT85525A (de) Arzneimittel enthaltend dipyridamol oder mopidamol und o-acetylsalicylsaeure bzw deren physiologish vertragliche salze verfahren zu ihrer herstellung und ihre verwendung bekampfung der thrombusbildung
ATA68386A (de) Verwendung von 3'-azido-3'-desoxythymidin oder eines pharmazeutisch annehmbaren derivats hievon zur herstellung von medikamenten
DK190885D0 (da) 2-(n-substitueret guanidino)-4-heteroarylthiazolderivater eller farmaceutisk acceptable syreadditionssalte deraf samt farmaceutisk praeparat indeholdende forbindelserne
IT8723126A0 (it) Derivati dell'acido tiazolidin 4carbossilico ad attivita'farmaceutica.
DE3778132D1 (de) 2-beta-substituierte methylpenicillansaeure-derivate und deren salze und ester.
DK112287A (da) Anvendelse af 2-alkoxy-n-(1-azabicyclo-oe2,2,2aaoct-3-yl)-benzamider og -thiobenzamider samt farmaceutisk acceptable syreadditionssalte deraf som laegemidler
KR870700618A (ko) 크로모글릭산유도체와 그 제조방법 및 약학적 조성물
FI854178A7 (fi) 1,2,4-triatsolo-karbamaatti ja sen happoadditiosuolat, näiden valmistusmenetelmät ja lääkeaineet.
ATA652178A (de) Verfahren zur herstellung von amidinosulfonsaeure- derivaten und von deren salzen pharmazeutische zusammensetzungen
AR245094A1 (es) Procedimiento para la fabricacion de acido benzoico y sales del mismo
DE68920063D1 (de) Derivate von Benzoesäure und Verfahren zu deren Herstellung.
DE3873167D1 (de) Thiazolidin-4-on-derivate und deren saeure-additionssalze.
PT86776A (pt) Process for the preparation of piperazinecarboxylic acid and pharmaceutical compositions containing it
FI890477A0 (fi) Menetelmä terapeuttisesti käyttökelpoisen 2,5-diamino-6-fluoriheksaanihapon ja sen suolojen valmistamiseksi
DE3577443D1 (de) Derivate von dihydroorotsaeure, deren verfahren zur herstellung und deren pharmazeutische zusammensetzungen.
DE3773716D1 (de) Verfahren zur herstellung von monosodiumsalz und dessen monohydrat von 1-beta-d-arabinofuranosylcytosin-5'stearylphosphat und diese enthaltende pharmazeutische zusammensetzung.
TR23828A (tr) Mikrobisid maddeler pirofosforoez asidin mikrobisid etkili tuzlari ve bunlarin imali icin usul
IT1198263B (it) Esteri dell'azoniaspironortropanolo,procedimento per la loro preparazione,mezzi farmaceutici che li contengono e impiego di esteri dell'azoniaspironortropanolo come spasmolitico,asmaterapeutico e broncolitico
FI944229A0 (fi) Astyylisalisyylihappoon tai sen suoloihin perustuva puristettu farmaseuttinen annosmuoto oraalista antoa varten ja menetelmä sen valmistamiseksi
FI892291A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 6-fenoksimetyyli-4-hydroksitetrahydropyran-2-onien ja 6-tiofenoksimetyyli-4-hydroksitetrahydropyran-2-onien sekä vastaavien dihydroksikarboksyylihappojohdannaisten, suolojen ja estereiden valmistamiseksi
DK357786A (da) Aromatiske estere af 1,4,5,6,7,8-hexahydro-2-alkyl-4-aryl-5-oxo-1,7-naphthyridin-3-carboxylsyre eller farmaceutiske acceptable salte deraf
DK149626C (da) Azepino(1,2-a)pyrimidinderivater eller pharmaceutisk acceptable syreadditionssalte deraf og et pharmaceutisk praeparat indeholdende disse
FI853025A7 (fi) 0(2,6-dikloorifenyyliamino) fenyylietikkahapon estereitä ja menetelmä niiden valmistamiseksi.
HU9201483D0 (en) Process for the production of 1h-rh-analogues'acid additive salts, and for the production of medical preparations containing them
DE3875460D1 (de) Arzneiformulierung zur transdermalen absorption des wirkstoffs sowie verfahren zu deren herstellung.